middle.news
Mayne Pharma Clears Key Antitrust Hurdle in Cosette Takeover Bid
10:22am on Wednesday 7th of May, 2025 AEST
•
Healthcare
Read Story
Mayne Pharma Clears Key Antitrust Hurdle in Cosette Takeover Bid
10:22am on Wednesday 7th of May, 2025 AEST
Key Points
Hart-Scott-Rodino antitrust waiting period expired
Key condition precedent for scheme implementation satisfied
Other approvals pending: FIRB, shareholder vote, court sanction
Scheme timetable remains on track as previously announced
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE